FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3175264784> ?p ?o ?g. }

• W3175264784 abstract "Endocrine therapy is administered to hormone-positive breast cancer patients to prevent distant metastasis. It is important to evaluate the risk of recurrence and to determine which patients are viable candidates for such treatment because hormone therapy has side effects that can include postmenopausal symptoms. The Clinical Treatment Score post-five years (CTS5), a simple tool for identifying candidates for endocrine therapy, was recently introduced; however, CTS5 only has been applied in validation studies with postmenopausal women. We aimed to validate CTS5 among premenopausal breast cancer patients.We identified patients treated between 1994 and 2014 at Samsung Medical Center in Seoul, Korea, and followed their treatment outcomes for more than 60 months after surgery using clinicopathologic parameters. According to menopausal status, we divided the study population into two groups: pre- and postmenopausal women. After calculating CTS5 values based on some parameters, we stratified the rate of late distant recurrence (DR) and analyzed the correlation between CTS5 value and late DR by risk.Among 16,904 patients treated surgically for breast cancer, 2,605 with hormone receptor-positive breast cancer who received endocrine therapy were included. Of these, 1,749 (67.14%) patients were premenopausal women, and the median age was 44.00 years. When categorizing study participants according to CTS5-related risk for late DR, 86.79% were categorized as low risk, 5.95% were categorized as intermediate risk, and 7.26% were categorized as high risk. The annual rate of DR was 1.41% for those in the present study and was similar between pre- and postmenopausal participants (1.40 vs. 1.42). Distant metastasis-free survival was not different between the two groups (hazard ratio: 0.817, 95% confidence interval [CI]: 0.547-1.221). The area under the receiver operating characteristic curve at 10 years for premenopausal and postmenopausal patients was 61.75 (95% CI: 52.97-70.53) and 72.71 (95% CIs: 63.30-82.12), respectively.Although CTS5 was able to predict late DR, it should be applied with caution in premenopausal women. A CTS5 calculator for premenopausal women might be needed to not underestimate the risk of recurrence in Korea." @default.
• W3175264784 created "2021-07-05" @default.
• W3175264784 creator A5016487381 @default.
• W3175264784 creator A5022604964 @default.
• W3175264784 creator A5031863352 @default.
• W3175264784 creator A5033852351 @default.
• W3175264784 creator A5055171803 @default.
• W3175264784 creator A5057636290 @default.
• W3175264784 creator A5068566980 @default.
• W3175264784 creator A5072805794 @default.
• W3175264784 date "2021-06-21" @default.
• W3175264784 modified "2023-09-24" @default.
• W3175264784 title "Validation of the Clinical Treatment Score Post–Five Years in Breast Cancer Patients for Predicting Late Distant Recurrence: A Single-Center Investigation in Korea" @default.
• W3175264784 cites W1491616134 @default.
• W3175264784 cites W1529243395 @default.
• W3175264784 cites W1531964529 @default.
• W3175264784 cites W1961026612 @default.
• W3175264784 cites W2012194655 @default.
• W3175264784 cites W2017803347 @default.
• W3175264784 cites W2022102157 @default.
• W3175264784 cites W2044702943 @default.
• W3175264784 cites W2105882193 @default.
• W3175264784 cites W2112780046 @default.
• W3175264784 cites W2114586150 @default.
• W3175264784 cites W2123618524 @default.
• W3175264784 cites W2131199058 @default.
• W3175264784 cites W2131584282 @default.
• W3175264784 cites W2133071015 @default.
• W3175264784 cites W2149615486 @default.
• W3175264784 cites W2151447010 @default.
• W3175264784 cites W2161977537 @default.
• W3175264784 cites W2166969772 @default.
• W3175264784 cites W2169649287 @default.
• W3175264784 cites W2267844613 @default.
• W3175264784 cites W2767600184 @default.
• W3175264784 cites W2788523770 @default.
• W3175264784 cites W2802363130 @default.
• W3175264784 cites W2806866264 @default.
• W3175264784 cites W2807648028 @default.
• W3175264784 cites W2896478308 @default.
• W3175264784 cites W2960282589 @default.
• W3175264784 cites W2968618875 @default.
• W3175264784 cites W2979238646 @default.
• W3175264784 cites W3011284322 @default.
• W3175264784 cites W3039706639 @default.
• W3175264784 cites W3043951483 @default.
• W3175264784 cites W3091960239 @default.
• W3175264784 doi "https://doi.org/10.3389/fonc.2021.691277" @default.
• W3175264784 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8257467" @default.
• W3175264784 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34239805" @default.
• W3175264784 hasPublicationYear "2021" @default.
• W3175264784 type Work @default.
• W3175264784 sameAs 3175264784 @default.
• W3175264784 citedByCount "2" @default.
• W3175264784 countsByYear W31752647842023 @default.
• W3175264784 crossrefType "journal-article" @default.
• W3175264784 hasAuthorship W3175264784A5016487381 @default.
• W3175264784 hasAuthorship W3175264784A5022604964 @default.
• W3175264784 hasAuthorship W3175264784A5031863352 @default.
• W3175264784 hasAuthorship W3175264784A5033852351 @default.
• W3175264784 hasAuthorship W3175264784A5055171803 @default.
• W3175264784 hasAuthorship W3175264784A5057636290 @default.
• W3175264784 hasAuthorship W3175264784A5068566980 @default.
• W3175264784 hasAuthorship W3175264784A5072805794 @default.
• W3175264784 hasBestOaLocation W31752647841 @default.
• W3175264784 hasConcept C121608353 @default.
• W3175264784 hasConcept C126322002 @default.
• W3175264784 hasConcept C143998085 @default.
• W3175264784 hasConcept C2779013556 @default.
• W3175264784 hasConcept C2780275930 @default.
• W3175264784 hasConcept C29456083 @default.
• W3175264784 hasConcept C3019926457 @default.
• W3175264784 hasConcept C46699223 @default.
• W3175264784 hasConcept C530470458 @default.
• W3175264784 hasConcept C71315377 @default.
• W3175264784 hasConcept C71924100 @default.
• W3175264784 hasConceptScore W3175264784C121608353 @default.
• W3175264784 hasConceptScore W3175264784C126322002 @default.
• W3175264784 hasConceptScore W3175264784C143998085 @default.
• W3175264784 hasConceptScore W3175264784C2779013556 @default.
• W3175264784 hasConceptScore W3175264784C2780275930 @default.
• W3175264784 hasConceptScore W3175264784C29456083 @default.
• W3175264784 hasConceptScore W3175264784C3019926457 @default.
• W3175264784 hasConceptScore W3175264784C46699223 @default.
• W3175264784 hasConceptScore W3175264784C530470458 @default.
• W3175264784 hasConceptScore W3175264784C71315377 @default.
• W3175264784 hasConceptScore W3175264784C71924100 @default.
• W3175264784 hasLocation W31752647841 @default.
• W3175264784 hasLocation W31752647842 @default.
• W3175264784 hasLocation W31752647843 @default.
• W3175264784 hasLocation W31752647844 @default.
• W3175264784 hasOpenAccess W3175264784 @default.
• W3175264784 hasPrimaryLocation W31752647841 @default.
• W3175264784 hasRelatedWork W1995299309 @default.
• W3175264784 hasRelatedWork W2106576262 @default.
• W3175264784 hasRelatedWork W2148796794 @default.
• W3175264784 hasRelatedWork W2224319365 @default.
• W3175264784 hasRelatedWork W2280074578 @default.
• W3175264784 hasRelatedWork W2322588448 @default.
• W3175264784 hasRelatedWork W2403739699 @default.

• next